会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • SYSTEMS AND METHODS FOR DETECTING OR VALIDATING SIGNALS IN THE PRESENCE OF NOISE
    • 用于在噪声存在下检测或确认信号的系统和方法
    • US20070135722A1
    • 2007-06-14
    • US11625432
    • 2007-01-22
    • Yayun Lin
    • Yayun Lin
    • A61B5/04
    • A61B5/7221A61B5/0452A61B5/046A61B5/7264A61N1/3704A61N1/3718
    • Detecting or validating signals such as cardiac beats can be performed in the presence of myopotential or other noise. An amplitude peak, which can be a candidate for a detected beat, can be used in a normalized or other weighted average, along with a preceding and subsequent sample. The weighted average is compared to a noise threshold. Based on the result, the amplitude peak is either deemed an actual beat (e.g., depolarization or repolarization), or noise. The described systems, devices, and methods can improve the accuracy of detecting an actual beat in the presence of noise, during normal sinus rhythm or during an arrhythmia such as ventricular fibrillation. This, in turn, improves the accuracy with which therapy is delivered or withheld by an implantable device.
    • 检测或验证心脏搏动等信号可以在有电位或其他噪声的情况下进行。 可以作为检测到的拍子的候选者的振幅峰值可以与归一化或其他加权平均值一起使用,以及前一个和后续的采样。 将加权平均值与噪声阈值进行比较。 基于该结果,振幅峰值被认为是实际的搏动(例如去极化或复极化)或噪声。 所描述的系统,装置和方法可以提高在正常窦性心律期间或在诸如心室颤动的心律失常期间在噪声存在下检测实际搏动的准确性。 这反过来又提高了可植入装置输送或保留治疗的准确性。
    • 14. 发明授权
    • Automatic multi-level therapy based on morphologic organization of an arrhythmia
    • 基于心律失常形态组织的自动多级疗法
    • US08583228B2
    • 2013-11-12
    • US13048582
    • 2011-03-15
    • Dan LiYayun Lin
    • Dan LiYayun Lin
    • A61N1/00
    • A61N1/3622A61B5/04525A61B5/0464A61N1/36585A61N1/3962
    • Methods and systems for selecting tachyarrhythmia therapy based on the morphological organization level of the arrhythmia are described. Morphological organization levels of arrhythmias are associated with cardiac therapies. The morphological organization levels are related to cardiac signal morphologies of the arrhythmias. An arrhythmia episode is detected and the morphological organization level of the arrhythmia episode is determined. A cardiac therapy associated with the morphological organization level of the arrhythmia episode is delivered to treat the arrhythmia. For example, the morphological organization levels may be associated with the cardiac therapies based on one or more of retrospective database analysis, patient therapy tolerance, and physician input. The associations may be static or may be dynamically adjusted based on therapy efficacy.
    • 描述了基于心律失常形态组织水平选择快速性心律失常治疗的方法和系统。 心律失常的形态学组织水平与心脏治疗有关。 形态组织水平与心律失常的心脏信号形态有关。 检测到心律失常发作,确定心律失常发作的形态组织水平。 与心律失常发作的形态组织水平相关的心脏治疗被递送以治疗心律失常。 例如,形态组织水平可以基于回顾性数据库分析,患者治疗耐受性和医师输入中的一种或多种与心脏疗法相关联。 协会可以是静态的,或者可以基于治疗功效来动态调整。
    • 16. 发明授权
    • Systems and methods for detecting or validating signals in the presence of noise
    • 在存在噪声的情况下检测或验证信号的系统和方法
    • US08078272B2
    • 2011-12-13
    • US11625432
    • 2007-01-22
    • Yayun Lin
    • Yayun Lin
    • A61B5/0402
    • A61B5/7221A61B5/0452A61B5/046A61B5/7264A61N1/3704A61N1/3718
    • Detecting or validating signals such as cardiac beats can be performed in the presence of myopotential or other noise. An amplitude peak, which can be a candidate for a detected beat, can be used in a normalized or other weighted average, along with a preceding and subsequent sample. The weighted average is compared to a noise threshold. Based on the result, the amplitude peak is either deemed an actual beat (e.g., depolarization or repolarization), or noise. The described systems, devices, and methods can improve the accuracy of detecting an actual beat in the presence of noise, during normal sinus rhythm or during an arrhythmia such as ventricular fibrillation. This, in turn, improves the accuracy with which therapy is delivered or withheld by an implantable device.
    • 检测或验证心脏搏动等信号可以在有电位或其他噪声的情况下进行。 可以作为检测到的拍子的候选者的振幅峰值可以与归一化或其他加权平均值一起使用,以及前一个和后续的采样。 将加权平均值与噪声阈值进行比较。 基于该结果,振幅峰值被认为是实际的搏动(例如去极化或复极化)或噪声。 所描述的系统,装置和方法可以提高在正常窦性心律期间或在诸如心室颤动的心律失常期间在噪声存在下检测实际搏动的准确性。 这反过来又提高了可植入装置输送或保留治疗的准确性。
    • 17. 发明授权
    • Arrhythmia discrimination based on determination of rate dependency
    • 基于速率依赖性确定的心律失常辨别
    • US07653431B2
    • 2010-01-26
    • US11312280
    • 2005-12-20
    • Shelley CazaresJaeho KimYayun LinCarlos Ricci
    • Shelley CazaresJaeho KimYayun LinCarlos Ricci
    • A61B5/04
    • A61B5/0464A61B5/04525A61B5/7264
    • Cardiac systems and methods provide for discriminating between supraventricular tachyarrhythmia and ventricular tachyarrhythmia based on a determination that the patient's supraventricular rhythm exhibits rate dependency. One approach involves determining if a patient's supraventricular rhythm exhibits rate dependent morphology. If the patient's supraventricular rhythm is determined to exhibit rate dependent morphology, an implantable device classifies a detected tachyarrhythmia episode based on one or more templates selected from a plurality of rate-indexed templates stored in the device. Determining if the supraventricular rhythm exhibits rate dependent morphology may also include determining one or more rates at which the rate dependent morphology occurs.
    • 心脏系统和方法基于确定患者的室上节律表现出速率依赖性,确定了室上性快速性心律失常与室性快速性心律失常之间的区别。 一种方法涉及确定患者的室上节律是否表现出速率依赖性形态。 如果确定患者的室上节律表现出与速率相关的形态,则可植入装置基于从存储在装置中的多个速率索引模板中选择的一个或多个模板来分类检测到的快速性心律失常发作。 确定室性心律显示出速率依赖性形态还可以包括确定发生速率依赖形态的一个或多个速率。
    • 19. 发明授权
    • Cardiac rhythm management systems and methods for detecting or validating cardiac beats in the presence of noise
    • 心脏节律管理系统和在有噪声的情况下检测或验证心脏搏动的方法
    • US07215993B2
    • 2007-05-08
    • US10213364
    • 2002-08-06
    • Yayun Lin
    • Yayun Lin
    • A61B5/0456
    • A61B5/7221A61B5/0452A61B5/046A61B5/7264A61N1/3704A61N1/3718
    • This document describes systems, devices, and methods for detecting or validating cardiac beats, such as in the presence of myopotential or other noise. In one example, an amplitude peak, which is a candidate for a detected cardiac beat, is used in a weighted average, along with a preceding and subsequent sample. The weighted average is compared to a noise threshold. Based on the result of comparison, the amplitude peak is either deemed an actual cardiac beat, or otherwise is deemed noise. The described systems, devices, and methods improve the accuracy of detecting an actual cardiac beat in the presence of noise, during normal sinus rhythm or during an arrhythmia such as ventricular fibrillation. This, in turn, improves the accuracy with which therapy is delivered or withheld by an implantable cardiac rhythm management device. In one example, such as where the system includes a cardiac signal detector with automatic gain control (AGC) circuitry, the weighted average is normalized.
    • 本文件描述了用于检测或验证心脏搏动的系统,设备和方法,例如在存在神经或其他噪声的情况下。 在一个示例中,作为检测到的心跳的候选者的振幅峰值与加权平均值一起使用,以及之前和随后的样本。 将加权平均值与噪声阈值进行比较。 基于比较结果,振幅峰值被认为是实际心跳,或者被认为是噪声。 所描述的系统,装置和方法提高了在正常窦性心律期间或在诸如心室颤动的心律失常期间在噪声存在下检测实际心搏的准确性。 这反过来又提高了植入式心律管理装置的治疗的输送或保留的准确性。 在一个示例中,例如系统包括具有自动增益控制(AGC)电路的心脏信号检测器的地方,加权平均值被归一化。
    • 20. 发明申请
    • Automatic multi-level therapy based on morphologic organization of an arrhythmia
    • 基于心律失常形态组织的自动多级疗法
    • US20070049974A1
    • 2007-03-01
    • US11209976
    • 2005-08-23
    • Dan LiYayun Lin
    • Dan LiYayun Lin
    • A61N1/00
    • A61N1/3622A61B5/04525A61B5/0464A61N1/36585A61N1/3962
    • Methods and systems for selecting tachyarrhythmia therapy based on the morphological organization level of the arrhythmia are described. Morphological organization levels of arrhythmias are associated with cardiac therapies. The morphological organization levels are related to cardiac signal morphologies of the arrhythmias. An arrhythmia episode is detected and the morphological organization level of the arrhythmia episode is determined. A cardiac therapy associated with the morphological organization level of the arrhythmia episode is delivered to treat the arrhythmia. For example, the morphological organization levels may be associated with the cardiac therapies based on one or more of retrospective database analysis patient therapy tolerance, and physician input. The associations may be static or may be dynamically adjusted based on therapy efficacy.
    • 描述了基于心律失常形态组织水平选择快速性心律失常治疗的方法和系统。 心律失常的形态学组织水平与心脏治疗有关。 形态组织水平与心律失常的心脏信号形态有关。 检测到心律失常发作,确定心律失常发作的形态组织水平。 与心律失常发作的形态组织水平相关的心脏治疗被递送以治疗心律失常。 例如,形态组织水平可以基于回顾性数据库分析患者治疗耐受性和医师输入中的一种或多种与心脏治疗相关联。 协会可以是静态的,或者可以基于治疗功效来动态调整。